Cart
sales@molnova.com
CP-724714
CAS No. 383432-38-0
CP-724714 ( CP724714; CP 724714; CP-724714 )
Catalog No. M17499 CAS No. 383432-38-0
CP-724714 is an effective and selective HER2/ErbB2 inhibitor (IC50: 10 nM), >640-fold selectivity against EGFR, Abl, InsR, PDGFR, IRG-1R, Src, VEGFR2, c-Met etc.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 48 | In Stock |
|
| 5MG | 78 | In Stock |
|
| 10MG | 143 | In Stock |
|
| 25MG | 258 | In Stock |
|
| 50MG | 429 | In Stock |
|
| 100MG | 626 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCP-724714
-
NoteResearch use only, not for human use.
-
Brief DescriptionCP-724714 is an effective and selective HER2/ErbB2 inhibitor (IC50: 10 nM), >640-fold selectivity against EGFR, Abl, InsR, PDGFR, IRG-1R, Src, VEGFR2, c-Met etc.
-
DescriptionCP-724714 is An orally bioavailable quinazoline with potential antineoplastic activity. CP-724,714 selectively binds to the intracellular domain of HER2, reversibly inhibiting its tyrosine kinase activity and resulting in suppression of tumor cell growth. HER2, a member of the epidermal growth factor receptor (EGFR) family, is overexpressed in many adenocarcinomas, particularly breast cancers.
-
SynonymsCP724714; CP 724714; CP-724714
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorHER2/ErbB2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number383432-38-0
-
Formula Weight469.54
-
Molecular FormulaC27H27N5O3
-
Purity98%
-
SolubilityDMSO : ≥ 50 mg/mL; 106.49 mM
-
SMILESCc1ncc(cc1)Oc1c(cc(cc1)Nc1ncnc2c1cc(cc2)/C=C/CNC(=O)COC)C
-
Chemical Name(E)-2-methoxy-N-(3-(4-(3-methyl-4-(6-methylpyridin-3-yloxy)phenylamino)quinazolin-6-yl)allyl)acetamide.
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jani JP, et al. Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor. Cancer Res, 2007, 67(20), 9887-9893.
molnova catalog
related products
-
Epidermal Growth Fac...
Epidermal Growth Factor?binds to epidermal growth factor receptor (EGFR) and stimulates cell growth and proliferation. It is approved for the treatment of diabetic foot ulcers.
-
Naquotinib mesylate
Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR.
-
Epertinib
Epertinib (S-222611) is a novel potent, orally active, reversible EGFR and HER2 inhibitor with IC50 of 1.48, 7.15 and 2.49 nM for EGFR, HER2 and HER4, respectively.
